Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Enfusion, Inc. Class A Common Stock (NY: ENFN )

10.07 +0.22 (+2.23%)
Official Closing Price Updated: 7:00 PM EST, Jan 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 245,810
Open 9.950
Bid (Size) 9.680 (1)
Ask (Size) 10.66 (1)
Prev. Close 9.850
Today's Range 9.880 - 10.12
52wk Range 7.520 - 11.38
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
This Analyst With 85% Accuracy Rate Sees Around 10% Upside In Alphabet - Here Are 5 Stock Picks For 2024 From Wall Street's Most Accurate Analysts
Via Benzinga
This Analyst With 82% Accuracy Rate Sees Around 28% Upside In Apple - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
Via Benzinga

Performance

YTD
+2.23%
+2.23%
1 Month
+0.70%
+0.70%
3 Month
+12.51%
+12.51%
6 Month
+16.42%
+16.42%
1 Year
+9.81%
+9.81%

More News

Read More
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Fastly Stock Gets IBD Rating Upgrade
Via Investor's Business Daily
Enfusion To Present at Upcoming Investor Events
From Enfusion, Inc.
Via Business Wire
A Glimpse Into The Expert Outlook On Enfusion Through 4 Analysts
Via Benzinga
Enfusion Announces Third Quarter 2024 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Key Leadership Team Additions to Drive Client Success and Fuel Innovation
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Date of Third Quarter 2024 Results
From Enfusion, Inc.
Via Business Wire
ENFN Investors Have Opportunity to Join Enfusion, Inc. Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
ENFN Investors Have Opportunity to Join Enfusion, Inc. Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
ENFN Stock Earnings: Enfusion Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Enfusion Announces Second Quarter 2024 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Introduces the Next Phase of Portfolio Workbench, Empowering Asset Managers with Increased Efficiency and Flexibility
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Date of Second Quarter 2024 Results
From Enfusion, Inc.
Via Business Wire
Enfusion To Present at Upcoming Investor Events
From Enfusion, Inc.
Via Business Wire
ENFN Stock Earnings: Enfusion Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Enfusion Announces First Quarter 2024 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Date of First Quarter 2024 Results
From Enfusion, Inc.
Via Business Wire
The 3 Most Undervalued Under-$10 Stocks to Buy in April 2024
Via InvestorPlace
Kayne Anderson Strengthens Investment Operations After Successful Platform Migration to Enfusion
From Enfusion
Via Business Wire
Wall Street Favorites: 3 Under-$10 Stocks with Strong Buy Ratings for March 2024
Via InvestorPlace
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.